Acadia Pharmaceuticals (ACAD) Shares Issued (2016 - 2025)
Historic Shares Issued for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $9.4 million.
- Acadia Pharmaceuticals' Shares Issued rose 341604.48% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year increase of 18308.44%. This contributed to the annual value of $6.8 million for FY2024, which is 7276.06% down from last year.
- Latest data reveals that Acadia Pharmaceuticals reported Shares Issued of $9.4 million as of Q3 2025, which was up 341604.48% from $16.0 million recorded in Q2 2025.
- Over the past 5 years, Acadia Pharmaceuticals' Shares Issued peaked at $16.0 million during Q2 2025, and registered a low of $268000.0 during Q3 2024.
- Moreover, its 5-year median value for Shares Issued was $3.6 million (2024), whereas its average is $4.5 million.
- As far as peak fluctuations go, Acadia Pharmaceuticals' Shares Issued soared by 434285.71% in 2023, and later plummeted by 9789.82% in 2024.
- Over the past 5 years, Acadia Pharmaceuticals' Shares Issued (Quarter) stood at $4.4 million in 2021, then plummeted by 63.02% to $1.6 million in 2022, then surged by 236.68% to $5.4 million in 2023, then plummeted by 63.77% to $2.0 million in 2024, then skyrocketed by 378.57% to $9.4 million in 2025.
- Its Shares Issued stands at $9.4 million for Q3 2025, versus $16.0 million for Q2 2025 and $1.8 million for Q1 2025.